Sofinnova Partners
Founded 1972 · Paris, France
Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.
Total investments
283
Successful exits
62
Funding raised
$154M
About the program
Sofinnova is based in Europe with offices in Paris, London, and Milan, but the firm has a global reach and is open to opportunities across the entire value chain from early-stage to growth/IPO.
Location
Program details
We sit on the boards of our companies, playing an active role in the formation phase and throughout the company's growth all the way to exit.
Investment offer
We invest in life sciences startups with a focus on healthcare and sustainability. We look for visionary entrepreneurs developing breakthrough technologies in biotech, biopharma, medtech, and industrial biotech. We proactively source deals, take a lead role, and are most often the first institutional investor in Seed and Series A financings.